Sarepta Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Sarepta Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q2 2024.
Sarepta Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $50.5M, a 6.54% increase year-over-year.
Sarepta Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $185M, a 2.43% decline year-over-year.
Sarepta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $183M, a 21.7% decline from 2022.
Sarepta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $233M, a 105% increase from 2021.
Sarepta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $114M, a 5.43% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$185M	$50.5M	+$3.1M	+6.54%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$182M	$40.7M	-$600K	-1.45%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-01
Q4 2023	$183M	$45.8M	-$4.76M	-9.42%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-28
Q3 2023	$187M	$48.1M	-$2.36M	-4.68%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-01
Q2 2023	$190M	$47.4M	-$55.5M	-53.9%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	$245M	$41.3M	+$12.1M	+41.4%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-01
Q4 2022	$233M	$50.5M	+$20.7M	+69.6%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-28
Q3 2022	$212M	$50.4M	+$23.7M	+88.9%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-01
Q2 2022	$189M	$103M	+$73.9M	+255%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-02
Q1 2022	$115M	$29.2M	+$690K	+2.42%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-02
Q4 2021	$114M	$29.8M	+$255K	+0.86%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-28
Q3 2021	$114M	$26.7M	-$219K	-0.81%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-02
Q2 2021	$114M	$29M	+$1.35M	+4.9%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-02
Q1 2021	$113M	$28.5M	+$4.48M	+18.7%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-04
Q4 2020	$108M	$29.5M	+$7.46M	+33.8%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-28
Q3 2020	$101M	$26.9M	+$6.27M	+30.4%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-03
Q2 2020	$94.3M	$27.6M	+$7.85M	+39.7%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-04
Q1 2020	$86.5M	$24M	+$7.89M	+48.9%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-05
Q4 2019	$78.6M	$22.1M	+$9.23M	+71.9%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-01
Q3 2019	$69.4M	$20.6M	+$9.15M	+79.7%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	$60.2M	$19.8M	+$4.48M	+29.3%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-05
Q1 2019	$55.7M	$16.1M	+$5.61M	+53.3%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-06
Q4 2018	$50.1M	$12.8M	+$5.47M	+74.3%	Oct 1, 2018	Dec 31, 2018	10-K	2021-03-01
Q3 2018	$44.7M	$11.5M	+$4.56M	+65.9%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018	$40.1M	$15.3M	+$4.81M	+46%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-07
Q1 2018	$35.3M	$10.5M	+$4.81M	+84.3%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-08
Q4 2017	$30.5M	$7.37M	+$497K	+7.24%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-26
Q3 2017	$30M	$6.92M	-$2.65M	-27.7%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-31
Q2 2017	$32.6M	$10.5M	+$3.64M	+53.2%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-08
Q1 2017	$29M	$5.71M	-$978K	-14.6%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-03
Q4 2016	$30M	$6.87M	+$521K	+8.21%	Oct 1, 2016	Dec 31, 2016	10-K	2019-02-28
Q3 2016	$29.4M	$9.57M	+$3.89M	+68.5%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-01
Q2 2016	$25.6M	$6.83M	+$900K	+15.2%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-03
Q1 2016	$24.7M	$6.69M	-$7.47M	-52.7%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-04
Q4 2015	$32.1M	$6.35M	+$581K	+10.1%	Oct 1, 2015	Dec 31, 2015	10-K	2018-03-01
Q3 2015	$31.5M	$5.68M	+$1.03M	+22.2%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-07
Q2 2015	$30.5M	$5.93M	+$343K	+6.14%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-09
Q1 2015	$30.2M	$14.2M	+$9.81M	+226%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-05
Q4 2014	$20.3M	$5.77M	+$2.12M	+58%	Oct 1, 2014	Dec 31, 2014	10-K	2017-02-28
Q3 2014	$18.2M	$4.65M	+$1.16M	+33.3%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-05
Q2 2014	$17.1M	$5.59M	+$3.27M	+141%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-06
Q1 2014	$13.8M	$4.34M	+$2.67M	+160%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-07
Q4 2013	$11.1M	$3.65M	+$2.41M	+195%	Oct 1, 2013	Dec 31, 2013	10-K	2016-02-25
Q3 2013	$8.71M	$3.49M	+$2.8M	+404%	Jul 1, 2013	Sep 30, 2013	10-Q	2013-11-12
Q2 2013	$5.92M	$2.32M	+$1.88M	+427%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-07
Q1 2013	$4.04M	$1.67M	+$963K	+136%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-08
Q4 2012	$3.08M	$1.24M			Oct 1, 2012	Dec 31, 2012	10-K	2015-02-26
Q3 2012		$692K			Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-12
Q2 2012		$440K	-$152K	-25.7%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-08
Q1 2012		$708K			Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-09
Q2 2011		$592K			Apr 1, 2011	Jun 30, 2011	10-Q	2012-11-07

* An asterisk sign (*) next to the value indicates that the value is likely invalid.